A novel model of liver cancer stem cells developed from induced pluripotent stem cells Original link: https://www.nature.com/articles/s41416-020-0792-z Abstract Background Liver cancer is the second most common cause of cancer-related...
Prostate Cancer Therapeutics Market Size Worth $12.0 Billion By 2025 The global prostate cancer therapeutics market is expected to reach USD 12.0 billion by 2025, according to a new report by Grand View Research, Inc. According to the American Cancer...
Rat, Mouse, and Primate Models of Chronic Glaucoma Show Sustained Elevation of Extracellular ATP and Altered Purinergic Signaling in the Posterior Eye ...
Resource: May 2014 Journal of Pain Research Abstract: In the last two decades, animal models have become important tools in understanding and treating pain, and in predicting analgesic efficacy. Although rodent models retain a dominant role ...
05-Jul-2019 By Melissa Fassbender Improving the prognostic value of early phase data is among one of several ways to increase the probability of successes in drug development, a process which has become more expensive as failure rates have risen, s...
Originated from Daily SupChina, author: JEREMY GOLDKORN Original link: http://supchina.com/2018/01/24/world-first-cloned-monkeys-born-china/ Researchers at the Chinese Academy of Sciences Institute of Neuroscience announced that they ha...
Original link: https://america.cgtn.com/2018/02/02/detection-kit-shows-promise-in-liver-cancer-patients Author: Frances Kuo Liver cancer is one of the world’s deadliest cancers. And, it’s particularly common in China. Now, new technology...
Copyright © 2021. Nonhuman Primate CRO – Pharmacology Efficacy, Preclinical and Nonclinical drug development | Prisys Biotech All rights reserved.